TradingFloor AI · Stock Terminal

LH - Ticker AI Digest

Laboratory Corporation of America Holdings 📰 1
335.11000000 | Today -0.42% ●
Desk Snapshot GO VIP Login
Important AI Risk Notice

Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.

Not investment advice. Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate. Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only. Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally. Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Laboratory Corporation of America Holdings in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, Today’s AI, and the deeper desks.
LH Data 2026-08-31 Preview Mode
Core Deck
Deep Dive Modules
Home

Digested News

Today's Catalysts (LH) 1
LH 14:40
Laboratory Corporation of America Holdings
LH or CRL: Which Is the Better Value Stock Right Now?
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Admission 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 2
LH 11:11
Laboratory Corporation of America Holdings
Why Labcorp (LH) Is Up 6.1% After FDA Approval, Medicare Coverage Of ColoSense At-Home Test
LH 10:00
Laboratory Corporation of America Holdings
Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
BlockListing 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Circular 0
No items for this category on selected date.
ClinicalTrial 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
DirectorateChange 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Dividend 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Form83 0
No items for this category on selected date.
GeneralMeeting 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
IssueOfEquity 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 1
LH 15:00
Laboratory Corporation of America Holdings
GENFIT: NASHnext®, Powered by GENFIT's Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp’s OnDemand Offering for Identification of At-Risk MASH
Litigation 0
No items for this category on selected date.
MonthlyFactsheet 0
No items for this category on selected date.
NAV 0
No items for this category on selected date.
NameChange 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
OwnShares 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
ProfitWarning 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Prospectus 0
No items for this category on selected date.
Reports 1
LH 14:30
Laboratory Corporation of America Holdings
Why Is Pediatrix Medical Group (MD) Down 1.7% Since Last Earnings Report?
Results 2
LH 19:15
Laboratory Corporation of America Holdings
Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026
LH 15:16
Laboratory Corporation of America Holdings
Testing & Diagnostics Services Stocks Q1 Results: Benchmarking RadNet (NASDAQ:RDNT)
SchemeOfArrangement 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
TVR 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
US News 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 23
LH 14:40
Laboratory Corporation of America Holdings
LH or CRL: Which Is the Better Value Stock Right Now?
LH 19:15
Laboratory Corporation of America Holdings
Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026
LH 08:57
Laboratory Corporation of America Holdings
Omada Health, Inc. (OMDA) Stock Jumps 10.5%: Will It Continue to Soar?
LH 11:11
Laboratory Corporation of America Holdings
Why Labcorp (LH) Is Up 6.1% After FDA Approval, Medicare Coverage Of ColoSense At-Home Test
LH 09:48
Laboratory Corporation of America Holdings
3 Mid-Cap Stocks Walking a Fine Line
LH 16:05
Laboratory Corporation of America Holdings
Q1 Earnings Highlights: Labcorp (NYSE:LH) Vs The Rest Of The Testing & Diagnostics Services Stocks
LH 14:55
Laboratory Corporation of America Holdings
Is it the Right Time to Add Labcorp Stock to Your Portfolio?
LH 14:13
Laboratory Corporation of America Holdings
3 Reasons LH is Risky and 1 Stock to Buy Instead
LH 11:02
Laboratory Corporation of America Holdings
Natera (NTRA) Stock Jumps 10.7%: Will It Continue to Soar?
LH 11:52
Laboratory Corporation of America Holdings
How Are Emerging Markets Supporting Abbott's EPD Momentum?
LH 21:04
Laboratory Corporation of America Holdings
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?
LH 12:10
Laboratory Corporation of America Holdings
How to Approach Abbott Stock Following Its Sharp YTD Decline?
LH 10:00
Laboratory Corporation of America Holdings
Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test
LH 12:31
Laboratory Corporation of America Holdings
Is Labcorp Holdings Stock Underperforming the Nasdaq?
LH 14:40
Laboratory Corporation of America Holdings
LH vs. CRL: Which Stock Is the Better Value Option?
LH 12:15
Laboratory Corporation of America Holdings
CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue?
LH 14:15
Laboratory Corporation of America Holdings
Strong Performance Continues at DHR's Biotechnology Unit: What's Next?
LH 12:53
Laboratory Corporation of America Holdings
2 S&P 500 Stocks for Long-Term Investors and 1 Facing Challenges
LH 15:00
Laboratory Corporation of America Holdings
GENFIT: NASHnext®, Powered by GENFIT's Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp’s OnDemand Offering for Identification of At-Risk MASH
LH 15:16
Laboratory Corporation of America Holdings
Testing & Diagnostics Services Stocks Q1 Results: Benchmarking RadNet (NASDAQ:RDNT)
LH 14:30
Laboratory Corporation of America Holdings
Why Is Pediatrix Medical Group (MD) Down 1.7% Since Last Earnings Report?
LH 09:10
Laboratory Corporation of America Holdings
Assessing Labcorp (LH) Valuation As Shares Cool And P/E Trails Healthcare Peers
LH 12:11
Laboratory Corporation of America Holdings
LH Expands Genetic Testing in CRC Through New Collab: Stock to Gain?

Today's AI

LH · Agentic Market Intelligence

LH intelligence is listening.

The engine is monitoring news, price structure, forecasts and financial changes. New scored evidence will appear here against this stock automatically.

Live catalyst scoringAI price pathsRisk-aware triggersFinancial blend
AI bias0.0
Bullish0
Bearish0
Today's AI Starts With News

1 live catalyst is opening Today’s AI for LH.

Start with the live headline tape first. Today’s AI findings sit next, and the AI Blend stack drops lower once the news context is framed. Financial Forecastist now feeds the blend too.
Live Tape Data 2026-08-31 Blend Lower Down
Read the alert tape first, then open Today’s AI findings. Use AI Expand on any card to open the AI explanation, results tables and financial forecast rows instantly.
1 Today
Front Of Desk
Laboratory Corporation of America Holdings has fresh news flow live now, so Today’s AI is leading with the tape before the blended signal stack below.
14:40 Today's Catalyst LH or CRL: Which Is the Better Value Stock Right Now?
Single-Ticker Today's AI
LH signal theatre built from scored market catalysts, automated AI forecasts, financial forecasting and live trigger logic.

This is the ticker-specific Today’s AI desk for Laboratory Corporation of America Holdings. It compresses the live catalyst tape, bullish and bearish scoring, AI price forecasts, financial forecasting and trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI + Financial Blend Buy / Sell Trigger Engine Today's AI Findings
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full LH Today’s AI cockpit.

Subscription turns this tab into a live signal desk with today’s news findings at the top, AI plus financial blend comparisons at the bottom, buy and sell trigger logic, and the full findings ledger behind every scored row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific Today’s AI stack, sentiment gauges, AI blend stage, and the full findings ledger for LH on 2026-08-31.

Fundamentals Matrix

About Laboratory Corporation of America Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, the company offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI-enabled Test Selection, a generative AI-enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. The company has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics. It also has a collaboration with Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer. The company was founded in 1995 and is headquartered in Burlington, North

🌐 Visit Official Website ↗

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
23.7B
Enterprise Value
29.8B
Public Float
99.5
Broker Target
310.1177
Shares Out
82.0M
Long Interest
0
Short Interest
0
Exchange
NYSE
Currency Code
USD
ISIN
US5049221055
Ex-Dividend
2026-05-29
Yield
1.01%
Dividend Rate
2.88
EPS
11.29
Index
S&P 500
Market
NYSE
Standard Lists
Not currently ranked
Sector
Software and Computer ServicesUS fundamentals
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

News And Alerts First

1 live alert now opens the financials desk for LH.

Start with the headline flow and alert tape first. Then drop straight into Financial Forecastist below for the revenue path, EPS shape, cash pressure and balance-sheet read while the catalyst context is still hot.
Live Alerts Data 2026-08-31 Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
1 Alerts
Front Of Desk
Laboratory Corporation of America Holdings has fresh filing flow live now, so the tape is framing the revenue, leverage and valuation story below.
14:40 Today's Alert LH or CRL: Which Is the Better Value Stock Right Now?
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
2.88
Ex Divi
2026-05-29
Earnings Date
-
Net Debt
6.7B
Cash
532.3M
EPS
11.29
Net Income
876.5M
Revenue
14.1B
Enterprise Value
29.8B
Trailing PE
25.589
Forward PE
15.873
Price Sales TTM
1.6749
Price Book MRQ
2.6717
EV Revenue
2.0913
EV EBITDA
14.3395
Financial Forecastist

Mixed financial engine

Revenue is accelerating +5.8% against the prior comparable period. Net margin is expanding by 1.5 pts. Net debt is building +1.8%.

Revenue +5.8% Net Income +30.5% FCF -165.6% Current Ratio 1.73x Forward Rev 3.8B
Mixed
Quarter Revenue
3.5B
+5.8%
vs prior comparable quarter
Net Margin
+7.9%
+1.5 pts
profitability pulse
Free Cash Flow
70.5M
-165.6%
cash conversion
Net Debt / EBITDA
11.4x
+1.8%
lower is cleaner
Revenue Engine

Latest quarter printed 3.5B with the top line pushing higher against the last comparable period.

Profit Stack

Net income landed at 277.8M and the margin profile is broadening. That usually tells us whether operating leverage is finally kicking in.

Balance-Sheet Pressure

Cash sits near 981.1M while net debt is 6.3B. The leverage stack is moving the wrong way.

Quarterly Revenue Runway

Actual revenue bars, consensus revenue where available, plus the terminal model path.

Profit And Cash Conversion

Net income and free cash flow moving together is usually what separates genuine improvement from noise.

Balance-Sheet Pressure

Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.

Annual Power Curve

Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q3 2025
Consensus
3.6B
Revenue Path
4.14
EPS / Earnings
Growth cue +0.2%
Q1 2026
Consensus
3.5B
Revenue Path
4.12
EPS / Earnings
Growth cue +0.1%
Q2 2026
Consensus
3.7B
Revenue Path
4.77
EPS / Earnings
Growth cue +0.1%
Q3 2026
Consensus
3.8B
Revenue Path
4.59
EPS / Earnings
Growth cue +0.1%
FY 2026
Consensus
14.7B
Revenue Path
17.98
EPS / Earnings
Growth cue +0.1%
FY 2027
Consensus
15.4B
Revenue Path
19.44
EPS / Earnings
Growth cue +0.1%

Quarterly Statement Tape

Last 6 Quarters
Period Revenue Net Income FCF Net Debt
Q1 2026 3.5B 277.8M 70.5M 6.3B
Q4 2025 3.5B 164.7M 490.3M 6.7B
Q3 2025 3.6B 261.1M 280.5M 6.6B
Q2 2025 3.5B 237.9M 542.7M 5.9B
Q1 2025 3.3B 212.8M -107.5M 6.2B
Q4 2024 3.3B 143.4M 665.1M 5.8B

Annual Financial Power

Last 5 Years
Period Revenue Net Income EBITDA FCF
FY 2025 14.0B 876.5M 2.0B 1.2B
FY 2024 13.0B 746.0M 1.8B 1.1B
FY 2023 12.2B 418.0M 1.3B 874.1M
FY 2022 11.9B 1.3B 2.0B 1.5B
FY 2021 13.1B 2.4B 3.7B 2.6B

Structure DNA

Market Structure DNA

Yield Compounder profile with trend runway open

Price is 95.2% through the 52-week range, +10.2% vs 50DMA and +8.1% vs 200DMA. 100.0% of the register is locked by institutions and insiders, leaving 0.0% free float. Capital rhythm reads quarterly with forward yield near 1.0% and payout around 17.1%.

Trend runway open Institutional gravity Reliable income rhythm As Of 2026-07-07
Yield Compounder
Structure Score
79.6 / 100
Yield Compounder
Trend Stack
+10.2% / +8.1%
vs 50DMA / 200DMA
52W Position
95.2%
auction position inside the yearly range
Ownership Lock
100.0%
101.0% institutions | 35.4% insiders
Pressure Pocket
4.0% short float
Short ratio 5.8x | monthly -3.1%
Capital Rhythm
Quarterly
Yield 1.0% | payout 17.1%
Trend Runway

Implied spot is 288.90 with the stock +10.2% vs 50DMA and +8.1% vs 200DMA. The tape is sitting 95.2% through the 52-week range, which frames the regime as trend runway open.

Ownership Register

Institutions hold about 101.0% and insiders about 35.4%, locking roughly 100.0% of the register and leaving 0.0% in free float. That reads as institutional gravity.

Pressure Pocket

Short pressure is running near 4.0% of float with short ratio 5.8x and monthly change -3.1%. That gives us a read on whether the tape is clean, crowded, or coiled.

Capital Rhythm

Dividend cadence reads quarterly with 4 event(s) in the last full year, a five-year average of 3.2, and stability score 60.0/100. Forward yield sits near 1.0% while payout is around 17.1%.

Structure Score

One-glance gauge for the current market-structure regime.

Pillar Radar

Trend, ownership, pressure, and capital rhythm mapped on one wheel.

Position And Float Balance

Shows whether the stock is extended, tightly held, or carrying capital-return support.

Dividend Cadence Tape

Historical dividend-event counts help reveal how dependable the income rhythm has been.

Dividend Cadence Ledger

Quarterly
Year Dividend Count Context
2026 2 Current partial year
2025 4 Full year
2024 4 Full year
2023 4 Full year
2022 3 Full year
1994 1 Full year
1993 4 Full year
1992 5 Full year

Structure Facts

Live Snapshot
Implied Spot
288.90
derived from market cap / shares
52W High
291.40
upper auction edge
52W Low
239.28
lower auction edge
Beta
0.86
volatility character
Shares Out
82.0M
fully diluted count
Shares Float
81.6M
tradable register
Shares Short
3.3M
borrowed stock
Short Ratio
5.8x
days-to-cover style read
Ex-Dividend
2026-05-29
-39 day(s) to ex-date
Dividend Pay
2026-06-11
-26 day(s) to pay date
Last Split
6:5
2014-04-29

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
94.337
Institutions As Of
2026-05-31
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
0
Sale Director Dealing
0
Purchase TR1
0
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
40
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data · LH · Last 30 Days

Short D · 12/26 EMA spread with 9 signal

Red histogram bars show short loading accelerating. Green bars show short covering accelerating. The two lines expose the crossover before the raw holder table does.

Short D waiting

Building LH short-momentum read

Short D compares the ticker’s disclosed short-position momentum with its own signal line.

Short D—
Signal—
Momentum—

Declared Short Holders

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

News And Alerts First

The alert tape opens the door for LH, and AI Charts sits just below.

Start with the headline flow and live catalyst tape first. Then move straight into AI Charts below for price reaction, AI targets, chart structure and catalyst beacons while the news context is still hot.
Live Tape Data 2026-08-31 AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
1 Today
Catalyst Pulse
Laboratory Corporation of America Holdings has fresh news flow live now, so the tape is framing the chart workspace below.
14:40 Today's Catalyst LH or CRL: Which Is the Better Value Stock Right Now?
AI Charts Studio
LH Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-08-31 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
Desk Snapshot Member Login
AI AutoDetection Automatic bull / bear chart read
Detected market structure
Analysing selected range
Why this call
Waiting for sufficient price history.
Invalidation
—
Updates with the timeframe.
Bull caseCalculating upside confirmation.
Bear caseCalculating downside confirmation.
Indicators0
Technicals0
RSI Gauge
Price Change
AI Forecast